Medtronic Neuroscience — Other segment items increased by 33.3% to $12.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $12.00M to $12.00M.
Large fluctuations may signal one-time charges, restructuring costs, or non-recurring gains that require further investigation.
This category aggregates miscellaneous expenses or income items specific to the Neuroscience segment that do not fit int...
Similar to 'other operating items' or 'unallocated segment expenses' found in segment reporting for large conglomerates.
mdt_segment_neuroscience_other_segment_items| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $18.50M | $18.50M | $18.50M | $18.50M | $11.00M | -$4.00M | $12.00M | -$2.00M | $2.00M | $9.00M | $12.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -40.5% | -136.4% | +400.0% | -116.7% | +200.0% | +350.0% | +33.3% |
| YoY Change | — | — | — | — | -40.5% | -121.6% | — | — | -81.8% | +325.0% | +0.0% |